Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis

Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.